Cutera, Inc. (NASDAQ:CUTR) CFO Ronald J. Santilli sold 12,000 shares of Cutera stock in a transaction that occurred on Wednesday, August 16th. The shares were sold at an average price of $34.00, for a total transaction of $408,000.00. Following the completion of the transaction, the chief financial officer now owns 75,253 shares of the company’s stock, valued at $2,558,602. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Cutera, Inc. (NASDAQ CUTR) opened at 33.75 on Monday. The firm has a 50-day moving average of $28.32 and a 200 day moving average of $22.96. Cutera, Inc. has a one year low of $10.54 and a one year high of $34.91. The company has a market capitalization of $472.67 million, a P/E ratio of 72.58 and a beta of 0.60.

Cutera (NASDAQ:CUTR) last announced its quarterly earnings data on Monday, August 7th. The medical device company reported $0.13 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.03 by $0.10. The firm had revenue of $36.40 million during the quarter, compared to analysts’ expectations of $32.08 million. Cutera had a net margin of 5.07% and a return on equity of 11.64%. The company’s revenue for the quarter was up 32.4% compared to the same quarter last year. During the same period in the prior year, the company posted $0.07 earnings per share. On average, equities analysts forecast that Cutera, Inc. will post $0.52 EPS for the current fiscal year.

Cutera declared that its board has authorized a stock buyback plan on Monday, August 7th that authorizes the company to buyback $25.00 million in shares. This buyback authorization authorizes the medical device company to purchase up to 6.8% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s board believes its stock is undervalued.

TRADEMARK VIOLATION NOTICE: This story was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another site, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark laws. The original version of this story can be read at https://www.thecerbatgem.com/2017/08/21/insider-selling-cutera-inc-cutr-cfo-sells-408000-00-in-stock.html.

CUTR has been the subject of a number of recent research reports. BidaskClub lowered shares of Cutera from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 19th. Gabelli reiterated a “buy” rating on shares of Cutera in a research note on Wednesday, August 9th. Maxim Group reissued a “buy” rating and issued a $33.00 price target (up from $27.00) on shares of Cutera in a report on Thursday, July 13th. Zacks Investment Research raised shares of Cutera from a “sell” rating to a “buy” rating and set a $28.00 price target for the company in a report on Tuesday, June 20th. Finally, Sidoti reissued a “buy” rating and issued a $32.00 price target (up from $30.00) on shares of Cutera in a report on Friday, July 7th. Six investment analysts have rated the stock with a buy rating, The stock has an average rating of “Buy” and an average price target of $33.25.

A number of institutional investors have recently bought and sold shares of CUTR. Icon Advisers Inc. Co. bought a new position in Cutera during the first quarter valued at $571,000. Driehaus Capital Management LLC bought a new position in Cutera during the first quarter valued at $363,000. Insight Capital Research & Management Inc. bought a new position in Cutera during the second quarter valued at $797,000. Oxford Asset Management boosted its position in Cutera by 98.4% in the first quarter. Oxford Asset Management now owns 52,100 shares of the medical device company’s stock valued at $1,078,000 after buying an additional 25,839 shares during the last quarter. Finally, Teachers Advisors LLC boosted its position in Cutera by 56.0% in the fourth quarter. Teachers Advisors LLC now owns 38,794 shares of the medical device company’s stock valued at $673,000 after buying an additional 13,923 shares during the last quarter. 84.44% of the stock is owned by institutional investors.

About Cutera

Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.

Insider Buying and Selling by Quarter for Cutera (NASDAQ:CUTR)

Receive News & Stock Ratings for Cutera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera Inc. and related stocks with our FREE daily email newsletter.